Morgan Stanley resumed coverage of Ovintiv (OVV) with an Overweight rating and $57 price target which offers 30% upside. The company’s recent acquisition in the Montney is 20% accretive to 2025 free cash flow per share and extends its inventory depth, the analyst tells investors in a research note. The firm sees opportunities for operational improvement on the acquired assets, as Ovintiv has demonstrated with its 2023 Permian acquisition.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OVV:
- Ovintiv upgraded to Outperform from Market Perform at BMO Capital
- Ovintiv price target raised to $45 from $44 at Wells Fargo
- Ovintiv price target lowered to $45 from $56 at JPMorgan
- Ovintiv price target lowered to $58 from $68 at Siebert Williams
- Ovintiv’s Growth Potential and Financial Stability Drive Buy Rating